NCT07935135: Study of CMP-002 in Participants With SYNGAP1-Related Disorder
- State
- Not started
- Phase
- Phase 1 and Phase 2
- People
- 80 planned
- Started
- Nov 2026
- Primary completion
- Jan 2029
- Arms
- CMP-002 Multiple Ascending Dose (MAD)
- Results
- None posted
- 13 Nov 2026: Trial registered